IXC
Click for more information
5.71% 7.4¢ invex therapeutics ltd

Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-13

  1. JabraD
    15,516 Posts.
    lightbulb Created with Sketch. 1280
    clock Created with Sketch.
    04/11/21
    09:57
    Post #: 57304695
    Got to remember EU market is 1 billion growing 3% annual, hit this one out of the park then we can focus on FDA. How many times have Companies approached it this way, countless.
    big derisk now as we know what to expect. Big re-rate for company coming when market catches on that we are at 17 mill EV for a company starting PHASE 3 trials
    IXC Price at posting: 65.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RDN If you thought lithium was dead, think again. The Pilbara will be central to the next upswing
right-arrow Created with Sketch.
BOT US FDA approves Botanix Pharma's excessive underarm sweat drug
right-arrow Created with Sketch.
JGH Jade's strong gas exploration results another step towards Mongolian development
right-arrow Created with Sketch.
NEWS Microcap Madness: 5 junior explorers with news out on Thursday 20 June
right-arrow Created with Sketch.
FHE Frontier Energy achieves key milestone for Waroona energy project
right-arrow Created with Sketch.
AML Cultural heritage agreement puts Walford Creek exploration back on the map
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.4¢ 		Change
0.004(5.71%) 		Mkt cap ! $5.561M
Open High Low Value Volume
7.1¢ 7.5¢ 7.1¢ $4.091K 54.95K

Buyers (Bids)

No. Vol. Price($)
1 198734 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.4¢ 29802 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.